Rajpurkar, M

Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature. [electronic resource] - Haemophilia : the official journal of the World Federation of Hemophilia Jul 2014 - 464-71 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1365-2516

10.1111/hae.12473 doi


Antibodies--immunology
Factor VIIa--adverse effects
Humans
Recombinant Proteins--adverse effects
Safety
Thrombasthenia--drug therapy
Treatment Failure